Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Panic Disorder | 78 | 2021 | 614 | 7.440 |
Why?
|
Depressive Disorder | 133 | 2011 | 3731 | 3.710 |
Why?
|
Fluoxetine | 75 | 2007 | 736 | 3.620 |
Why?
|
Anxiety Disorders | 81 | 2021 | 2706 | 3.600 |
Why?
|
Child of Impaired Parents | 26 | 2021 | 459 | 3.320 |
Why?
|
Clonazepam | 30 | 2004 | 133 | 2.100 |
Why?
|
Depressive Disorder, Major | 54 | 2021 | 4731 | 1.850 |
Why?
|
Agoraphobia | 29 | 2012 | 177 | 1.630 |
Why?
|
Phobic Disorders | 33 | 2012 | 436 | 1.540 |
Why?
|
Antidepressive Agents, Second-Generation | 25 | 2005 | 489 | 1.520 |
Why?
|
Anger | 19 | 2008 | 403 | 1.400 |
Why?
|
Antidepressive Agents | 39 | 2015 | 2886 | 1.390 |
Why?
|
Psychiatric Status Rating Scales | 96 | 2008 | 6021 | 1.200 |
Why?
|
Temperament | 15 | 2013 | 289 | 1.190 |
Why?
|
Child Behavior Disorders | 12 | 2007 | 803 | 1.180 |
Why?
|
Benzodiazepines | 18 | 2020 | 1126 | 1.170 |
Why?
|
Panic | 27 | 1991 | 103 | 1.160 |
Why?
|
Alprazolam | 24 | 2003 | 98 | 0.990 |
Why?
|
Anti-Anxiety Agents | 14 | 2020 | 397 | 0.960 |
Why?
|
Substance Withdrawal Syndrome | 15 | 2004 | 623 | 0.950 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 10 | 2012 | 307 | 0.840 |
Why?
|
Psychotropic Drugs | 11 | 2010 | 883 | 0.810 |
Why?
|
Bipolar Disorder | 28 | 2010 | 5074 | 0.770 |
Why?
|
Hallucinogens | 1 | 2024 | 189 | 0.750 |
Why?
|
Lithium | 23 | 2015 | 595 | 0.720 |
Why?
|
Anxiety, Separation | 9 | 2010 | 86 | 0.710 |
Why?
|
Comorbidity | 59 | 2012 | 10538 | 0.700 |
Why?
|
Desipramine | 13 | 2004 | 184 | 0.680 |
Why?
|
Hypericum | 3 | 2013 | 58 | 0.610 |
Why?
|
Personality Inventory | 33 | 2010 | 1021 | 0.600 |
Why?
|
Personality Disorders | 14 | 2005 | 719 | 0.570 |
Why?
|
Child Behavior | 10 | 2007 | 845 | 0.560 |
Why?
|
Ambulatory Care | 38 | 2007 | 2763 | 0.550 |
Why?
|
Imipramine | 15 | 1997 | 98 | 0.540 |
Why?
|
Fear | 19 | 2004 | 1457 | 0.530 |
Why?
|
Double-Blind Method | 54 | 2013 | 12348 | 0.490 |
Why?
|
GABA Modulators | 3 | 2000 | 109 | 0.490 |
Why?
|
Mental Disorders | 18 | 2013 | 6799 | 0.490 |
Why?
|
Antidepressive Agents, Tricyclic | 12 | 2004 | 432 | 0.480 |
Why?
|
Personality Assessment | 16 | 2010 | 651 | 0.470 |
Why?
|
Expressed Emotion | 4 | 2007 | 93 | 0.470 |
Why?
|
Phytotherapy | 3 | 2013 | 293 | 0.450 |
Why?
|
Adult | 219 | 2021 | 217991 | 0.440 |
Why?
|
Personality Development | 11 | 2003 | 244 | 0.440 |
Why?
|
Cyclohexanols | 3 | 2000 | 126 | 0.440 |
Why?
|
Research Design | 15 | 2024 | 6143 | 0.430 |
Why?
|
Hostility | 8 | 2008 | 185 | 0.430 |
Why?
|
Psychopharmacology | 4 | 2005 | 141 | 0.430 |
Why?
|
Anxiety | 13 | 2015 | 4484 | 0.420 |
Why?
|
Pregnancy Complications | 9 | 2004 | 2924 | 0.410 |
Why?
|
Humans | 336 | 2024 | 755562 | 0.410 |
Why?
|
Adolescent Psychiatry | 1 | 2013 | 150 | 0.400 |
Why?
|
Female | 245 | 2015 | 387930 | 0.390 |
Why?
|
Drug Administration Schedule | 34 | 2007 | 4887 | 0.390 |
Why?
|
Placebos | 20 | 2004 | 1667 | 0.390 |
Why?
|
1-Naphthylamine | 5 | 1998 | 49 | 0.380 |
Why?
|
Male | 224 | 2015 | 356589 | 0.380 |
Why?
|
Substance-Related Disorders | 11 | 2013 | 4357 | 0.370 |
Why?
|
Clinical Trials as Topic | 21 | 2008 | 8013 | 0.370 |
Why?
|
Social Adjustment | 9 | 2007 | 633 | 0.360 |
Why?
|
Psychiatry | 6 | 2009 | 1694 | 0.360 |
Why?
|
Mood Disorders | 4 | 2010 | 1121 | 0.350 |
Why?
|
Severity of Illness Index | 35 | 2007 | 15746 | 0.340 |
Why?
|
Puerperal Disorders | 4 | 1995 | 300 | 0.310 |
Why?
|
Adolescent | 85 | 2021 | 87237 | 0.310 |
Why?
|
S-Adenosylmethionine | 7 | 1999 | 213 | 0.290 |
Why?
|
Shyness | 5 | 2004 | 21 | 0.290 |
Why?
|
Treatment Outcome | 79 | 2013 | 64540 | 0.290 |
Why?
|
Commitment of Mentally Ill | 1 | 2007 | 96 | 0.290 |
Why?
|
Sexual Dysfunctions, Psychological | 4 | 2002 | 191 | 0.290 |
Why?
|
Child | 58 | 2021 | 79428 | 0.280 |
Why?
|
Dose-Response Relationship, Drug | 28 | 2004 | 10811 | 0.280 |
Why?
|
Thyrotropin | 7 | 1996 | 830 | 0.280 |
Why?
|
Birth Order | 1 | 2006 | 96 | 0.270 |
Why?
|
Depression, Postpartum | 3 | 1995 | 347 | 0.270 |
Why?
|
Risk Factors | 50 | 2015 | 73861 | 0.270 |
Why?
|
September 11 Terrorist Attacks | 1 | 2007 | 104 | 0.270 |
Why?
|
Suicide, Attempted | 3 | 2010 | 1373 | 0.260 |
Why?
|
Attention | 3 | 2013 | 2374 | 0.260 |
Why?
|
Middle Aged | 141 | 2015 | 218062 | 0.260 |
Why?
|
Child, Preschool | 35 | 2021 | 41893 | 0.250 |
Why?
|
Referral and Consultation | 5 | 2006 | 3580 | 0.250 |
Why?
|
Hospitals, General | 4 | 2004 | 767 | 0.240 |
Why?
|
Age of Onset | 14 | 2006 | 3304 | 0.240 |
Why?
|
Life Change Events | 5 | 2004 | 950 | 0.230 |
Why?
|
Thyrotropin-Releasing Hormone | 6 | 1996 | 139 | 0.230 |
Why?
|
Managed Care Programs | 3 | 1998 | 935 | 0.230 |
Why?
|
Television | 1 | 2007 | 409 | 0.230 |
Why?
|
Drug Therapy, Combination | 23 | 2006 | 6481 | 0.230 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 9 | 2008 | 3689 | 0.230 |
Why?
|
Personality | 5 | 2010 | 549 | 0.230 |
Why?
|
Monoamine Oxidase Inhibitors | 7 | 2002 | 155 | 0.220 |
Why?
|
Age Factors | 14 | 2013 | 18366 | 0.220 |
Why?
|
Paroxetine | 5 | 2001 | 182 | 0.220 |
Why?
|
Patient Dropouts | 7 | 2003 | 411 | 0.210 |
Why?
|
Longitudinal Studies | 23 | 2010 | 14384 | 0.210 |
Why?
|
Hippocampus | 1 | 2015 | 3724 | 0.210 |
Why?
|
Violence | 2 | 2007 | 926 | 0.210 |
Why?
|
Follow-Up Studies | 37 | 2012 | 39181 | 0.210 |
Why?
|
Mothers | 3 | 2005 | 2177 | 0.210 |
Why?
|
Lithium Chloride | 1 | 2002 | 82 | 0.200 |
Why?
|
Prolactin | 4 | 2003 | 631 | 0.200 |
Why?
|
Social Environment | 5 | 2004 | 1016 | 0.200 |
Why?
|
Parents | 7 | 2008 | 3530 | 0.200 |
Why?
|
Bioethics | 1 | 2003 | 115 | 0.200 |
Why?
|
Fenfluramine | 2 | 2003 | 60 | 0.190 |
Why?
|
Recurrence | 21 | 2010 | 8441 | 0.190 |
Why?
|
Thymopoietins | 1 | 2000 | 10 | 0.180 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 7 | 2008 | 1986 | 0.180 |
Why?
|
Estrogen Replacement Therapy | 3 | 1999 | 1205 | 0.180 |
Why?
|
Family Health | 5 | 2007 | 1261 | 0.180 |
Why?
|
Dopamine Agonists | 2 | 2000 | 351 | 0.180 |
Why?
|
Depression | 9 | 2021 | 7961 | 0.180 |
Why?
|
Dysthymic Disorder | 2 | 1997 | 75 | 0.180 |
Why?
|
Vitamin B 12 | 4 | 2005 | 518 | 0.180 |
Why?
|
Arousal | 7 | 2008 | 1144 | 0.170 |
Why?
|
Societies, Medical | 2 | 2014 | 3856 | 0.170 |
Why?
|
Homocysteine | 4 | 2005 | 638 | 0.170 |
Why?
|
Epidemiologic Research Design | 1 | 2003 | 367 | 0.170 |
Why?
|
Aggression | 5 | 2000 | 743 | 0.170 |
Why?
|
Cerebral Cortex | 2 | 2013 | 5731 | 0.170 |
Why?
|
Prevalence | 18 | 2008 | 15590 | 0.170 |
Why?
|
Cocaine | 3 | 1991 | 984 | 0.170 |
Why?
|
Alcoholism | 4 | 2001 | 1948 | 0.160 |
Why?
|
Thiazoles | 3 | 2004 | 1506 | 0.160 |
Why?
|
Hydrocortisone | 6 | 2003 | 1801 | 0.160 |
Why?
|
Pregnancy Outcome | 3 | 2001 | 2869 | 0.160 |
Why?
|
Climacteric | 2 | 1999 | 57 | 0.160 |
Why?
|
Orgasm | 3 | 2002 | 61 | 0.160 |
Why?
|
Benzodiazepinones | 3 | 1986 | 50 | 0.160 |
Why?
|
Obsessive-Compulsive Disorder | 6 | 2012 | 1485 | 0.160 |
Why?
|
Triazoles | 1 | 2004 | 907 | 0.150 |
Why?
|
Seasonal Affective Disorder | 2 | 1995 | 49 | 0.150 |
Why?
|
Premenstrual Syndrome | 2 | 1999 | 107 | 0.150 |
Why?
|
Economics, Medical | 1 | 1998 | 110 | 0.150 |
Why?
|
Defense Mechanisms | 1 | 1998 | 180 | 0.150 |
Why?
|
Analysis of Variance | 7 | 2004 | 6237 | 0.140 |
Why?
|
Neurotic Disorders | 1 | 1997 | 77 | 0.140 |
Why?
|
Vagus Nerve | 1 | 2000 | 456 | 0.140 |
Why?
|
Sick Role | 2 | 1996 | 231 | 0.140 |
Why?
|
Bupropion | 2 | 2000 | 305 | 0.140 |
Why?
|
Dopamine Agents | 1 | 1998 | 189 | 0.140 |
Why?
|
Tubulin | 1 | 2000 | 699 | 0.140 |
Why?
|
Carbon Dioxide | 3 | 1994 | 1145 | 0.140 |
Why?
|
Sex | 1 | 1996 | 53 | 0.140 |
Why?
|
Pilot Projects | 12 | 2006 | 8487 | 0.140 |
Why?
|
Probability | 9 | 2013 | 2478 | 0.140 |
Why?
|
Folic Acid | 4 | 2005 | 1299 | 0.140 |
Why?
|
Mother-Child Relations | 2 | 1997 | 488 | 0.130 |
Why?
|
Cocaine-Related Disorders | 1 | 1999 | 464 | 0.130 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2007 | 4505 | 0.130 |
Why?
|
History, 20th Century | 3 | 2011 | 2759 | 0.130 |
Why?
|
Hypochondriasis | 1 | 1996 | 93 | 0.130 |
Why?
|
Sertraline | 6 | 2000 | 208 | 0.130 |
Why?
|
Aged | 68 | 2015 | 167382 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2013 | 10248 | 0.130 |
Why?
|
Antipsychotic Agents | 5 | 2004 | 3057 | 0.130 |
Why?
|
Combined Modality Therapy | 12 | 2006 | 8555 | 0.130 |
Why?
|
Attitude | 3 | 1999 | 773 | 0.130 |
Why?
|
Research | 1 | 2004 | 1969 | 0.120 |
Why?
|
Lung Diseases | 2 | 1996 | 1905 | 0.120 |
Why?
|
Microtubules | 1 | 2000 | 1078 | 0.120 |
Why?
|
Complementary Therapies | 1 | 1999 | 486 | 0.120 |
Why?
|
Phototherapy | 2 | 1995 | 367 | 0.120 |
Why?
|
Progesterone Congeners | 1 | 1994 | 44 | 0.120 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 1995 | 273 | 0.120 |
Why?
|
Endpoint Determination | 2 | 2008 | 592 | 0.120 |
Why?
|
Self Concept | 2 | 1997 | 1027 | 0.120 |
Why?
|
Drug Resistance | 7 | 2004 | 1611 | 0.120 |
Why?
|
Behavior, Addictive | 1 | 1999 | 461 | 0.110 |
Why?
|
Electric Stimulation Therapy | 1 | 2000 | 610 | 0.110 |
Why?
|
Obstetric Labor Complications | 1 | 1996 | 236 | 0.110 |
Why?
|
Mental Health Services | 2 | 2003 | 1715 | 0.110 |
Why?
|
Caffeine | 2 | 1996 | 698 | 0.110 |
Why?
|
Adolescent Medicine | 1 | 2014 | 73 | 0.110 |
Why?
|
Socioeconomic Factors | 5 | 2005 | 7782 | 0.110 |
Why?
|
Thinking | 1 | 1996 | 315 | 0.110 |
Why?
|
Anticonvulsants | 2 | 2001 | 1894 | 0.110 |
Why?
|
Hyperthyroidism | 1 | 1995 | 293 | 0.110 |
Why?
|
Psychotic Disorders | 6 | 2015 | 3159 | 0.110 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 2005 | 361 | 0.110 |
Why?
|
Accident Proneness | 1 | 1992 | 4 | 0.110 |
Why?
|
Abnormalities, Drug-Induced | 3 | 1997 | 339 | 0.100 |
Why?
|
Protein Processing, Post-Translational | 1 | 2000 | 1961 | 0.100 |
Why?
|
Thyroid Hormones | 1 | 1995 | 400 | 0.100 |
Why?
|
Risk | 6 | 2012 | 9624 | 0.100 |
Why?
|
Risk Management | 2 | 1993 | 557 | 0.100 |
Why?
|
Accidents | 1 | 1993 | 166 | 0.100 |
Why?
|
Biomedical Research | 2 | 2008 | 3390 | 0.100 |
Why?
|
Nicotine | 1 | 1996 | 676 | 0.100 |
Why?
|
Plant Extracts | 2 | 2005 | 495 | 0.100 |
Why?
|
Odds Ratio | 5 | 2007 | 9720 | 0.100 |
Why?
|
Risk Assessment | 5 | 2020 | 23957 | 0.090 |
Why?
|
Auditory Perception | 2 | 1996 | 575 | 0.090 |
Why?
|
Half-Life | 4 | 1998 | 650 | 0.090 |
Why?
|
Menstrual Cycle | 1 | 1994 | 534 | 0.090 |
Why?
|
Prospective Studies | 21 | 2008 | 53994 | 0.090 |
Why?
|
Research Personnel | 2 | 2008 | 580 | 0.090 |
Why?
|
Chi-Square Distribution | 5 | 2002 | 3469 | 0.090 |
Why?
|
Psychotherapy, Group | 1 | 1994 | 407 | 0.090 |
Why?
|
Ethanol | 1 | 1996 | 1329 | 0.090 |
Why?
|
Social Behavior Disorders | 2 | 2003 | 96 | 0.090 |
Why?
|
Pregnancy | 14 | 2004 | 29543 | 0.090 |
Why?
|
Organ Size | 1 | 2015 | 2250 | 0.090 |
Why?
|
Hypothyroidism | 1 | 1995 | 665 | 0.090 |
Why?
|
Heroin Dependence | 1 | 1991 | 177 | 0.090 |
Why?
|
Psychometrics | 8 | 2010 | 3027 | 0.090 |
Why?
|
Lithium Carbonate | 7 | 2004 | 180 | 0.090 |
Why?
|
Wounds and Injuries | 2 | 1993 | 2447 | 0.090 |
Why?
|
Renal Insufficiency | 1 | 2015 | 811 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 8 | 2008 | 17703 | 0.080 |
Why?
|
Ethics, Research | 2 | 2008 | 173 | 0.080 |
Why?
|
Dexamethasone | 3 | 1993 | 1927 | 0.080 |
Why?
|
Data Interpretation, Statistical | 2 | 2010 | 2686 | 0.080 |
Why?
|
Independent Living | 1 | 2013 | 563 | 0.080 |
Why?
|
Infant | 11 | 2008 | 35867 | 0.080 |
Why?
|
Central Nervous System Stimulants | 1 | 1998 | 1164 | 0.080 |
Why?
|
Long-Term Care | 4 | 2002 | 621 | 0.080 |
Why?
|
Prognosis | 12 | 2007 | 29424 | 0.080 |
Why?
|
Buspirone | 1 | 1989 | 81 | 0.080 |
Why?
|
Estrogens | 1 | 1995 | 1520 | 0.080 |
Why?
|
Clomipramine | 3 | 1993 | 54 | 0.080 |
Why?
|
Serotonin | 4 | 2003 | 1031 | 0.080 |
Why?
|
Case-Control Studies | 9 | 2014 | 21906 | 0.080 |
Why?
|
Choline | 3 | 1999 | 512 | 0.080 |
Why?
|
Cholesterol | 3 | 2004 | 2920 | 0.080 |
Why?
|
Animal Experimentation | 1 | 2008 | 45 | 0.080 |
Why?
|
Single-Blind Method | 4 | 2013 | 1574 | 0.080 |
Why?
|
RGS Proteins | 1 | 2008 | 75 | 0.080 |
Why?
|
Ejaculation | 1 | 1988 | 59 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1994 | 1250 | 0.080 |
Why?
|
Gastroenterology | 1 | 2014 | 562 | 0.070 |
Why?
|
Psychotherapy | 3 | 1996 | 1636 | 0.070 |
Why?
|
Sex Factors | 7 | 2005 | 10493 | 0.070 |
Why?
|
Antimanic Agents | 3 | 2002 | 520 | 0.070 |
Why?
|
Circadian Rhythm | 2 | 2000 | 2563 | 0.070 |
Why?
|
Family | 3 | 1994 | 3181 | 0.070 |
Why?
|
Social Behavior | 4 | 2004 | 1132 | 0.070 |
Why?
|
Drug Synergism | 3 | 2002 | 1748 | 0.070 |
Why?
|
Reference Values | 3 | 2006 | 4914 | 0.070 |
Why?
|
Verapamil | 1 | 1987 | 242 | 0.070 |
Why?
|
Suicide | 4 | 1999 | 1606 | 0.070 |
Why?
|
Avoidance Learning | 1 | 2008 | 251 | 0.070 |
Why?
|
Interview, Psychological | 2 | 2005 | 811 | 0.070 |
Why?
|
Logistic Models | 4 | 2008 | 13315 | 0.070 |
Why?
|
Physician's Role | 2 | 2007 | 918 | 0.070 |
Why?
|
Somatoform Disorders | 2 | 2002 | 421 | 0.070 |
Why?
|
Diagnosis, Differential | 11 | 1999 | 12926 | 0.070 |
Why?
|
Family Conflict | 1 | 2007 | 95 | 0.070 |
Why?
|
Psychopathology | 2 | 2012 | 425 | 0.070 |
Why?
|
Statistics as Topic | 3 | 2006 | 2355 | 0.070 |
Why?
|
Sensation | 1 | 1988 | 331 | 0.070 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2008 | 490 | 0.070 |
Why?
|
Amygdala | 1 | 2014 | 1340 | 0.070 |
Why?
|
Appetite | 3 | 1999 | 247 | 0.070 |
Why?
|
Hospitalization | 4 | 1999 | 10683 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2014 | 15682 | 0.060 |
Why?
|
Receptors, GABA-A | 1 | 1990 | 626 | 0.060 |
Why?
|
Drug Interactions | 3 | 2004 | 1421 | 0.060 |
Why?
|
Stereotyping | 1 | 2007 | 240 | 0.060 |
Why?
|
Basal Ganglia | 2 | 1999 | 549 | 0.060 |
Why?
|
Behavior Therapy | 4 | 1993 | 860 | 0.060 |
Why?
|
Secondary Prevention | 5 | 2006 | 1547 | 0.060 |
Why?
|
Piperazines | 3 | 2004 | 2506 | 0.060 |
Why?
|
Terrorism | 1 | 2008 | 213 | 0.060 |
Why?
|
Terminology as Topic | 4 | 2001 | 1532 | 0.060 |
Why?
|
Patient Advocacy | 1 | 2007 | 358 | 0.060 |
Why?
|
Memory | 1 | 1994 | 2171 | 0.060 |
Why?
|
History, 21st Century | 1 | 2011 | 1559 | 0.060 |
Why?
|
Dichotic Listening Tests | 2 | 1996 | 22 | 0.060 |
Why?
|
Affect | 2 | 2010 | 1487 | 0.060 |
Why?
|
Body Weight | 6 | 2004 | 4606 | 0.060 |
Why?
|
Facial Expression | 1 | 2008 | 511 | 0.060 |
Why?
|
Home Care Services | 1 | 1991 | 642 | 0.060 |
Why?
|
Regression Analysis | 3 | 2006 | 6364 | 0.060 |
Why?
|
Inpatients | 2 | 1993 | 2579 | 0.060 |
Why?
|
Conflict of Interest | 1 | 2009 | 547 | 0.060 |
Why?
|
Adaptation, Psychological | 1 | 1995 | 2606 | 0.060 |
Why?
|
Time Factors | 14 | 2014 | 39963 | 0.060 |
Why?
|
Drug Therapy | 1 | 2007 | 502 | 0.060 |
Why?
|
Administration, Oral | 5 | 1995 | 4017 | 0.060 |
Why?
|
Survival Analysis | 7 | 2002 | 10180 | 0.060 |
Why?
|
Assertiveness | 2 | 1994 | 18 | 0.050 |
Why?
|
Nortriptyline | 1 | 2003 | 79 | 0.050 |
Why?
|
Selection Bias | 1 | 2004 | 356 | 0.050 |
Why?
|
Internship and Residency | 1 | 2003 | 5832 | 0.050 |
Why?
|
Attitude of Health Personnel | 2 | 2008 | 3832 | 0.050 |
Why?
|
Internal-External Control | 2 | 2002 | 359 | 0.050 |
Why?
|
Cognition | 3 | 1995 | 6884 | 0.050 |
Why?
|
Pattern Recognition, Visual | 1 | 2008 | 810 | 0.050 |
Why?
|
Human Experimentation | 1 | 2003 | 125 | 0.050 |
Why?
|
Drug Industry | 1 | 2009 | 787 | 0.050 |
Why?
|
Goals | 1 | 2007 | 705 | 0.050 |
Why?
|
Benzothiazoles | 2 | 2000 | 249 | 0.050 |
Why?
|
Fathers | 1 | 2005 | 371 | 0.050 |
Why?
|
Disease Susceptibility | 3 | 2000 | 1774 | 0.050 |
Why?
|
Ethics | 1 | 2002 | 94 | 0.050 |
Why?
|
Stress, Psychological | 2 | 1996 | 4378 | 0.050 |
Why?
|
Placebo Effect | 4 | 2002 | 512 | 0.050 |
Why?
|
Age Distribution | 2 | 2000 | 2887 | 0.050 |
Why?
|
Pregnancy Trimester, Third | 2 | 1994 | 584 | 0.050 |
Why?
|
Libido | 1 | 2002 | 120 | 0.050 |
Why?
|
Biological Science Disciplines | 1 | 2001 | 55 | 0.050 |
Why?
|
Pain, Intractable | 1 | 1982 | 130 | 0.050 |
Why?
|
Interpersonal Relations | 2 | 2007 | 1425 | 0.050 |
Why?
|
Tetrahymena | 1 | 2000 | 10 | 0.050 |
Why?
|
Primary Health Care | 1 | 1998 | 4633 | 0.050 |
Why?
|
Urinary Incontinence | 1 | 1985 | 492 | 0.050 |
Why?
|
Apgar Score | 1 | 2001 | 127 | 0.050 |
Why?
|
Coronary Disease | 1 | 1996 | 5993 | 0.050 |
Why?
|
Informed Consent | 1 | 2007 | 997 | 0.050 |
Why?
|
Brain | 6 | 2008 | 26738 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2007 | 15197 | 0.050 |
Why?
|
Retrospective Studies | 17 | 2007 | 79688 | 0.050 |
Why?
|
Massachusetts | 5 | 2004 | 8735 | 0.050 |
Why?
|
Drug Discovery | 1 | 2008 | 1060 | 0.040 |
Why?
|
Molecular Motor Proteins | 1 | 2000 | 105 | 0.040 |
Why?
|
Arginine Vasopressin | 1 | 2000 | 125 | 0.040 |
Why?
|
Glutamate Decarboxylase | 1 | 2001 | 239 | 0.040 |
Why?
|
Health Care Surveys | 2 | 2014 | 2429 | 0.040 |
Why?
|
Executive Function | 1 | 2009 | 1361 | 0.040 |
Why?
|
Genotype | 5 | 2008 | 12891 | 0.040 |
Why?
|
Water Intoxication | 1 | 1979 | 10 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 1999 | 3757 | 0.040 |
Why?
|
Fluvoxamine | 1 | 1999 | 77 | 0.040 |
Why?
|
Causality | 1 | 2006 | 1236 | 0.040 |
Why?
|
L-Selectin | 1 | 2000 | 207 | 0.040 |
Why?
|
Choice Behavior | 2 | 2008 | 810 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2012 | 25698 | 0.040 |
Why?
|
Benzophenones | 1 | 1999 | 58 | 0.040 |
Why?
|
Career Mobility | 1 | 2001 | 257 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2010 | 2278 | 0.040 |
Why?
|
Cohort Studies | 8 | 2006 | 41119 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2014 | 2414 | 0.040 |
Why?
|
Sleep | 5 | 1996 | 4692 | 0.040 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 1999 | 300 | 0.040 |
Why?
|
Hospitals | 1 | 1993 | 3926 | 0.040 |
Why?
|
Parent-Child Relations | 1 | 2004 | 755 | 0.040 |
Why?
|
Tryptophan | 1 | 2001 | 485 | 0.040 |
Why?
|
Hypotension, Orthostatic | 3 | 1987 | 254 | 0.040 |
Why?
|
Pediatrics | 1 | 2014 | 3582 | 0.040 |
Why?
|
Family Characteristics | 1 | 2004 | 1002 | 0.040 |
Why?
|
Neurotransmitter Agents | 2 | 2000 | 655 | 0.040 |
Why?
|
Psychiatric Department, Hospital | 1 | 1999 | 126 | 0.040 |
Why?
|
Dominance, Cerebral | 2 | 2008 | 627 | 0.040 |
Why?
|
Drug Tolerance | 1 | 2000 | 372 | 0.040 |
Why?
|
Pemoline | 1 | 1998 | 18 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2000 | 627 | 0.040 |
Why?
|
Decision Trees | 1 | 2000 | 504 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2015 | 36045 | 0.040 |
Why?
|
Erectile Dysfunction | 1 | 2002 | 453 | 0.040 |
Why?
|
Health Status | 2 | 2004 | 4056 | 0.040 |
Why?
|
Lung Diseases, Obstructive | 2 | 1996 | 308 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4678 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2003 | 2846 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2003 | 1695 | 0.040 |
Why?
|
Entrepreneurship | 1 | 1998 | 23 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2000 | 986 | 0.040 |
Why?
|
Observer Variation | 1 | 2004 | 2593 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2003 | 1037 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2004 | 14636 | 0.040 |
Why?
|
Outpatients | 4 | 2004 | 1593 | 0.040 |
Why?
|
Phenelzine | 2 | 1988 | 27 | 0.040 |
Why?
|
Labor, Obstetric | 1 | 2001 | 319 | 0.040 |
Why?
|
Triazines | 1 | 1999 | 311 | 0.040 |
Why?
|
Patient Care Planning | 1 | 2003 | 902 | 0.040 |
Why?
|
Attitude to Health | 2 | 2005 | 2029 | 0.040 |
Why?
|
Capitation Fee | 1 | 1998 | 117 | 0.040 |
Why?
|
Creatine | 1 | 1999 | 425 | 0.040 |
Why?
|
Disease Progression | 4 | 2010 | 13429 | 0.040 |
Why?
|
Headache | 3 | 1999 | 1238 | 0.040 |
Why?
|
Histrionic Personality Disorder | 1 | 1996 | 10 | 0.040 |
Why?
|
Social Support | 1 | 2007 | 2134 | 0.030 |
Why?
|
Problem Solving | 1 | 1999 | 440 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2000 | 2936 | 0.030 |
Why?
|
Delayed-Action Preparations | 2 | 1997 | 962 | 0.030 |
Why?
|
Linkage Disequilibrium | 3 | 2008 | 1990 | 0.030 |
Why?
|
Boston | 2 | 2007 | 9254 | 0.030 |
Why?
|
Citalopram | 3 | 2005 | 402 | 0.030 |
Why?
|
Nerve Net | 1 | 2008 | 2212 | 0.030 |
Why?
|
Cytosol | 1 | 1999 | 885 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 58027 | 0.030 |
Why?
|
Sleep Initiation and Maintenance Disorders | 4 | 2003 | 1067 | 0.030 |
Why?
|
Behavioral Sciences | 1 | 1996 | 29 | 0.030 |
Why?
|
Physicians | 1 | 2014 | 4558 | 0.030 |
Why?
|
Health Services Research | 1 | 2003 | 1810 | 0.030 |
Why?
|
Fascioliasis | 3 | 1969 | 14 | 0.030 |
Why?
|
Sampling Studies | 1 | 1997 | 617 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5290 | 0.030 |
Why?
|
Compulsive Personality Disorder | 1 | 1995 | 48 | 0.030 |
Why?
|
Career Choice | 1 | 2001 | 753 | 0.030 |
Why?
|
Chronic Disease | 6 | 2004 | 9180 | 0.030 |
Why?
|
Drug Prescriptions | 2 | 2002 | 1663 | 0.030 |
Why?
|
Treatment Failure | 2 | 2003 | 2637 | 0.030 |
Why?
|
Proportional Hazards Models | 4 | 2003 | 12500 | 0.030 |
Why?
|
Treatment Refusal | 2 | 1997 | 427 | 0.030 |
Why?
|
Health Maintenance Organizations | 1 | 1998 | 659 | 0.030 |
Why?
|
Narcissism | 1 | 1995 | 64 | 0.030 |
Why?
|
Culture | 1 | 1999 | 622 | 0.030 |
Why?
|
Amines | 2 | 1967 | 280 | 0.030 |
Why?
|
Clinical Protocols | 3 | 2006 | 1436 | 0.030 |
Why?
|
Personality Tests | 2 | 1991 | 81 | 0.030 |
Why?
|
Models, Animal | 1 | 2001 | 2117 | 0.030 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2008 | 324 | 0.030 |
Why?
|
Infant, Newborn | 5 | 2001 | 26039 | 0.030 |
Why?
|
Neurologic Examination | 1 | 1997 | 910 | 0.030 |
Why?
|
Educational Status | 1 | 2002 | 2509 | 0.030 |
Why?
|
Thyroid Function Tests | 1 | 1995 | 289 | 0.030 |
Why?
|
Mental Status Schedule | 1 | 1995 | 314 | 0.030 |
Why?
|
Algorithms | 1 | 1995 | 13952 | 0.030 |
Why?
|
Rage | 1 | 1993 | 30 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 1994 | 362 | 0.030 |
Why?
|
Antisocial Personality Disorder | 1 | 1995 | 226 | 0.030 |
Why?
|
Propranolol | 2 | 1986 | 489 | 0.030 |
Why?
|
Syndrome | 3 | 1997 | 3276 | 0.030 |
Why?
|
Condoms | 1 | 1996 | 316 | 0.030 |
Why?
|
Bulimia | 1 | 1996 | 399 | 0.030 |
Why?
|
Models, Psychological | 2 | 1996 | 826 | 0.030 |
Why?
|
Triiodothyronine | 1 | 1995 | 493 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 4286 | 0.030 |
Why?
|
Phenotype | 6 | 2008 | 16478 | 0.030 |
Why?
|
Awareness | 1 | 1997 | 618 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 3675 | 0.030 |
Why?
|
Fee-for-Service Plans | 1 | 1998 | 702 | 0.030 |
Why?
|
Blood Pressure | 3 | 1999 | 8495 | 0.030 |
Why?
|
Pregnanes | 1 | 1972 | 7 | 0.030 |
Why?
|
Ethics, Medical | 1 | 1998 | 788 | 0.030 |
Why?
|
Models, Statistical | 2 | 2004 | 5065 | 0.030 |
Why?
|
Electroconvulsive Therapy | 1 | 1998 | 504 | 0.030 |
Why?
|
Fatigue | 1 | 1999 | 1531 | 0.030 |
Why?
|
Aging | 2 | 2007 | 8594 | 0.030 |
Why?
|
Gene Frequency | 3 | 2005 | 3588 | 0.030 |
Why?
|
Professional Practice | 1 | 2014 | 311 | 0.030 |
Why?
|
Accident Prevention | 1 | 1992 | 76 | 0.020 |
Why?
|
Hypertension | 5 | 2015 | 8527 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 1997 | 588 | 0.020 |
Why?
|
Thyroxine | 1 | 1995 | 666 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 1994 | 735 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2008 | 8953 | 0.020 |
Why?
|
Data Collection | 2 | 2001 | 3306 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 1996 | 1674 | 0.020 |
Why?
|
Chromosome Mapping | 3 | 2005 | 4629 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2225 | 0.020 |
Why?
|
Patient Transfer | 1 | 1998 | 776 | 0.020 |
Why?
|
Airway Obstruction | 1 | 1996 | 655 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2003 | 4413 | 0.020 |
Why?
|
Respiratory Tract Diseases | 1 | 1996 | 748 | 0.020 |
Why?
|
Australia | 1 | 2014 | 1282 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2003 | 4942 | 0.020 |
Why?
|
Psychomotor Performance | 2 | 2009 | 1872 | 0.020 |
Why?
|
Self Efficacy | 1 | 2014 | 625 | 0.020 |
Why?
|
Patient Education as Topic | 2 | 2014 | 2304 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 1994 | 903 | 0.020 |
Why?
|
Pyrrolidines | 1 | 1972 | 337 | 0.020 |
Why?
|
Chest Pain | 1 | 1997 | 1105 | 0.020 |
Why?
|
Brain Chemistry | 1 | 1993 | 963 | 0.020 |
Why?
|
Trazodone | 1 | 1989 | 68 | 0.020 |
Why?
|
Xerostomia | 2 | 1987 | 94 | 0.020 |
Why?
|
Curriculum | 1 | 2003 | 3670 | 0.020 |
Why?
|
Motivation | 1 | 1999 | 1991 | 0.020 |
Why?
|
Drug Costs | 1 | 1998 | 1179 | 0.020 |
Why?
|
Functional Laterality | 1 | 1996 | 2261 | 0.020 |
Why?
|
Postpartum Period | 1 | 1996 | 1166 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 1991 | 386 | 0.020 |
Why?
|
Glomerular Filtration Rate | 2 | 2015 | 2115 | 0.020 |
Why?
|
Alleles | 3 | 2008 | 6890 | 0.020 |
Why?
|
Receptors, Dopamine | 1 | 1990 | 293 | 0.020 |
Why?
|
Stroop Test | 1 | 2009 | 72 | 0.020 |
Why?
|
Therapeutic Equivalency | 1 | 1989 | 136 | 0.020 |
Why?
|
Patient Compliance | 3 | 1997 | 2684 | 0.020 |
Why?
|
Animal Rights | 1 | 2008 | 10 | 0.020 |
Why?
|
Incidence | 4 | 2007 | 21240 | 0.020 |
Why?
|
Diazepam | 1 | 1989 | 215 | 0.020 |
Why?
|
Nitrophenols | 3 | 1999 | 167 | 0.020 |
Why?
|
Methadone | 1 | 1991 | 312 | 0.020 |
Why?
|
Protein Binding | 1 | 2000 | 9309 | 0.020 |
Why?
|
Light | 1 | 1994 | 1338 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2014 | 934 | 0.020 |
Why?
|
Drug Monitoring | 1 | 1994 | 965 | 0.020 |
Why?
|
Dehydroepiandrosterone | 1 | 1989 | 257 | 0.020 |
Why?
|
Abruptio Placentae | 1 | 1989 | 118 | 0.020 |
Why?
|
Safety | 1 | 1993 | 1147 | 0.020 |
Why?
|
Control Groups | 1 | 2008 | 105 | 0.020 |
Why?
|
United States | 4 | 2011 | 71889 | 0.020 |
Why?
|
Nausea | 3 | 1999 | 673 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3555 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2010 | 987 | 0.020 |
Why?
|
Morbidity | 1 | 1993 | 1762 | 0.020 |
Why?
|
Dothiepin | 1 | 1986 | 1 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2000 | 4280 | 0.020 |
Why?
|
Dibenzothiepins | 1 | 1986 | 9 | 0.020 |
Why?
|
Reproducibility of Results | 4 | 2002 | 19987 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1996 | 2198 | 0.020 |
Why?
|
Crime | 1 | 2008 | 201 | 0.020 |
Why?
|
Cluster Analysis | 1 | 1994 | 2691 | 0.020 |
Why?
|
Random Allocation | 5 | 1989 | 2390 | 0.020 |
Why?
|
Mental Processes | 1 | 2008 | 242 | 0.020 |
Why?
|
Speech Perception | 1 | 1991 | 506 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 1992 | 723 | 0.020 |
Why?
|
Verbal Learning | 1 | 2009 | 465 | 0.020 |
Why?
|
Acute Disease | 2 | 1987 | 7224 | 0.020 |
Why?
|
Body Mass Index | 3 | 2004 | 12838 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2014 | 1401 | 0.020 |
Why?
|
Substance Abuse, Intravenous | 1 | 1991 | 531 | 0.020 |
Why?
|
Genetic Markers | 2 | 2003 | 2607 | 0.020 |
Why?
|
Tremor | 1 | 1987 | 187 | 0.020 |
Why?
|
Mandelic Acids | 1 | 1985 | 46 | 0.020 |
Why?
|
Phenols | 1 | 1969 | 514 | 0.020 |
Why?
|
Urination Disorders | 1 | 1987 | 242 | 0.020 |
Why?
|
Primates | 1 | 2008 | 530 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5863 | 0.020 |
Why?
|
Constipation | 2 | 1987 | 555 | 0.020 |
Why?
|
Dihydrotestosterone | 1 | 1966 | 195 | 0.020 |
Why?
|
Health Personnel | 1 | 1999 | 3281 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2003 | 7434 | 0.020 |
Why?
|
Dizziness | 2 | 1998 | 247 | 0.020 |
Why?
|
Amitriptyline | 1 | 1985 | 112 | 0.020 |
Why?
|
Cholinesterase Inhibitors | 1 | 1986 | 237 | 0.010 |
Why?
|
Health Care Costs | 1 | 1998 | 3228 | 0.010 |
Why?
|
Chemistry | 3 | 1972 | 347 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2715 | 0.010 |
Why?
|
Chemical Phenomena | 3 | 1972 | 508 | 0.010 |
Why?
|
Sleep Stages | 2 | 1999 | 675 | 0.010 |
Why?
|
Connective Tissue Diseases | 1 | 1987 | 285 | 0.010 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2004 | 42 | 0.010 |
Why?
|
Dangerous Behavior | 1 | 1984 | 66 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 1996 | 2332 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 1987 | 691 | 0.010 |
Why?
|
Radioimmunoassay | 2 | 1996 | 873 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 1996 | 3998 | 0.010 |
Why?
|
Health Promotion | 1 | 1996 | 2208 | 0.010 |
Why?
|
Neuropsychological Tests | 2 | 2009 | 6978 | 0.010 |
Why?
|
Drug Combinations | 1 | 1989 | 2011 | 0.010 |
Why?
|
von Willebrand Factor | 1 | 1987 | 674 | 0.010 |
Why?
|
Affective Disorders, Psychotic | 1 | 1984 | 186 | 0.010 |
Why?
|
Mental Recall | 1 | 2009 | 1198 | 0.010 |
Why?
|
Quality of Health Care | 1 | 1998 | 4364 | 0.010 |
Why?
|
Hospitals, Psychiatric | 1 | 1984 | 323 | 0.010 |
Why?
|
Juvenile Delinquency | 1 | 2003 | 118 | 0.010 |
Why?
|
Reaction Time | 1 | 2009 | 2069 | 0.010 |
Why?
|
Obesity | 1 | 2004 | 12843 | 0.010 |
Why?
|
Coffee | 1 | 1986 | 582 | 0.010 |
Why?
|
Caregivers | 1 | 2014 | 2190 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3554 | 0.010 |
Why?
|
Memory, Short-Term | 1 | 2008 | 969 | 0.010 |
Why?
|
Steroids | 1 | 1967 | 923 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 1985 | 923 | 0.010 |
Why?
|
Achievement | 1 | 2003 | 290 | 0.010 |
Why?
|
Competitive Behavior | 1 | 2001 | 78 | 0.010 |
Why?
|
Education, Graduate | 1 | 2001 | 75 | 0.010 |
Why?
|
Financial Support | 1 | 2001 | 115 | 0.010 |
Why?
|
Psychomotor Agitation | 1 | 2003 | 306 | 0.010 |
Why?
|
Enkephalins | 1 | 2001 | 138 | 0.010 |
Why?
|
Receptors, Purinergic P1 | 1 | 2001 | 108 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3215 | 0.010 |
Why?
|
Receptor, Adenosine A2A | 1 | 2001 | 128 | 0.010 |
Why?
|
Sample Size | 1 | 2004 | 837 | 0.010 |
Why?
|
Lod Score | 1 | 2001 | 602 | 0.010 |
Why?
|
Infant Behavior | 1 | 2001 | 154 | 0.010 |
Why?
|
Nuclear Family | 1 | 2001 | 311 | 0.010 |
Why?
|
Communication | 1 | 2014 | 3814 | 0.010 |
Why?
|
Animals | 7 | 2008 | 167153 | 0.010 |
Why?
|
Salaries and Fringe Benefits | 1 | 2001 | 255 | 0.010 |
Why?
|
Conduct Disorder | 1 | 2001 | 243 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2001 | 431 | 0.010 |
Why?
|
Vision Disorders | 1 | 1987 | 1077 | 0.010 |
Why?
|
Inappropriate ADH Syndrome | 1 | 1979 | 61 | 0.010 |
Why?
|
Urinary Bladder | 1 | 1985 | 1170 | 0.010 |
Why?
|
Kidney | 2 | 1987 | 7009 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1646 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2001 | 639 | 0.010 |
Why?
|
Inositol | 1 | 1999 | 215 | 0.010 |
Why?
|
Schizophrenia | 2 | 2015 | 6897 | 0.010 |
Why?
|
Brain Mapping | 1 | 2014 | 6533 | 0.010 |
Why?
|
Behavior | 1 | 2001 | 541 | 0.010 |
Why?
|
Caudate Nucleus | 1 | 1999 | 394 | 0.010 |
Why?
|
Quantitative Trait, Heritable | 1 | 2001 | 538 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2000 | 776 | 0.010 |
Why?
|
Emergency Service, Hospital | 2 | 1997 | 7774 | 0.010 |
Why?
|
Research Support as Topic | 1 | 2001 | 699 | 0.010 |
Why?
|
Professional Competence | 1 | 2000 | 432 | 0.010 |
Why?
|
Protein Precursors | 1 | 2001 | 1131 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5844 | 0.010 |
Why?
|
Schizophrenic Psychology | 1 | 1984 | 1646 | 0.010 |
Why?
|
Oxygen | 1 | 2008 | 4177 | 0.010 |
Why?
|
Mass Screening | 1 | 2012 | 5413 | 0.010 |
Why?
|
Hyponatremia | 1 | 1979 | 280 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4574 | 0.010 |
Why?
|
Universities | 1 | 2001 | 976 | 0.010 |
Why?
|
Folic Acid Deficiency | 1 | 1997 | 115 | 0.010 |
Why?
|
Mutation | 1 | 2000 | 29807 | 0.010 |
Why?
|
Receptors, Serotonin | 1 | 1997 | 205 | 0.010 |
Why?
|
Emotions | 1 | 2008 | 2721 | 0.010 |
Why?
|
Vitamin B 12 Deficiency | 1 | 1997 | 119 | 0.010 |
Why?
|
Paresthesia | 1 | 1997 | 162 | 0.010 |
Why?
|
Anorexia Nervosa | 1 | 1985 | 1356 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2001 | 2385 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2000 | 2476 | 0.010 |
Why?
|
Amino Acids | 1 | 2001 | 1715 | 0.010 |
Why?
|
Kidney Concentrating Ability | 2 | 1987 | 36 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2000 | 1863 | 0.010 |
Why?
|
Publishing | 1 | 2001 | 835 | 0.010 |
Why?
|
Occupations | 1 | 1996 | 513 | 0.010 |
Why?
|
Norepinephrine | 1 | 1997 | 898 | 0.010 |
Why?
|
Calcium | 1 | 1987 | 5706 | 0.010 |
Why?
|
Spectrophotometry, Atomic | 1 | 1993 | 81 | 0.010 |
Why?
|
Hormone Replacement Therapy | 1 | 1999 | 750 | 0.010 |
Why?
|
Models, Structural | 1 | 1993 | 341 | 0.010 |
Why?
|
Pedigree | 1 | 2001 | 4579 | 0.010 |
Why?
|
Fellowships and Scholarships | 1 | 2001 | 1102 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2001 | 1856 | 0.010 |
Why?
|
Fluorine | 1 | 1992 | 84 | 0.010 |
Why?
|
Frontal Lobe | 1 | 1999 | 1408 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 1996 | 1227 | 0.010 |
Why?
|
Lymphocytes | 1 | 2000 | 2597 | 0.010 |
Why?
|
Saliva | 1 | 1996 | 813 | 0.010 |
Why?
|
Pattern Recognition, Automated | 1 | 1998 | 992 | 0.010 |
Why?
|
Fractures, Bone | 1 | 1984 | 2024 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2000 | 1790 | 0.010 |
Why?
|
Kidney Diseases | 1 | 1981 | 2062 | 0.010 |
Why?
|
Thiothixene | 1 | 1990 | 3 | 0.010 |
Why?
|
Fasciola hepatica | 1 | 1969 | 15 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2003 | 5496 | 0.010 |
Why?
|
Employment | 1 | 1996 | 1113 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1992 | 1382 | 0.010 |
Why?
|
Down-Regulation | 1 | 1997 | 2911 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2000 | 5846 | 0.010 |
Why?
|
Dioxins | 1 | 1969 | 92 | 0.010 |
Why?
|
Weight Gain | 1 | 1999 | 2333 | 0.010 |
Why?
|
Quality of Life | 2 | 2003 | 13201 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2003 | 12753 | 0.000 |
Why?
|
Ataxia | 1 | 1991 | 306 | 0.000 |
Why?
|
Dyspnea | 1 | 1996 | 1346 | 0.000 |
Why?
|
Pituitary-Adrenal System | 1 | 1991 | 550 | 0.000 |
Why?
|
Weight Loss | 1 | 1999 | 2667 | 0.000 |
Why?
|
Social Class | 1 | 1996 | 1995 | 0.000 |
Why?
|
Carbamazepine | 1 | 1988 | 225 | 0.000 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 1991 | 699 | 0.000 |
Why?
|
Sulfur Compounds | 1 | 1987 | 34 | 0.000 |
Why?
|
Pulse | 1 | 1987 | 218 | 0.000 |
Why?
|
Haloperidol | 1 | 1988 | 390 | 0.000 |
Why?
|
Patient Admission | 1 | 1994 | 1383 | 0.000 |
Why?
|
Anthelmintics | 1 | 1966 | 81 | 0.000 |
Why?
|
Naphthyridines | 1 | 1987 | 137 | 0.000 |
Why?
|
Rabbits | 2 | 1969 | 4768 | 0.000 |
Why?
|
Cats | 1 | 1986 | 968 | 0.000 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 1989 | 512 | 0.000 |
Why?
|
Quinolines | 1 | 1969 | 754 | 0.000 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 1997 | 3334 | 0.000 |
Why?
|
Mice | 2 | 2001 | 80750 | 0.000 |
Why?
|
Diet | 1 | 2001 | 7966 | 0.000 |
Why?
|
Child Abuse | 1 | 1992 | 1066 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2000 | 11898 | 0.000 |
Why?
|
Creatinine | 1 | 1987 | 1899 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1987 | 3786 | 0.000 |
Why?
|
Kidney Function Tests | 1 | 1981 | 681 | 0.000 |
Why?
|
Gestational Age | 1 | 1988 | 3557 | 0.000 |
Why?
|
Child Development | 1 | 1990 | 2270 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 1 | 1985 | 2247 | 0.000 |
Why?
|
Aged, 80 and over | 2 | 1988 | 58551 | 0.000 |
Why?
|
Cyanates | 1 | 1969 | 20 | 0.000 |
Why?
|
Sheep | 1 | 1966 | 1437 | 0.000 |
Why?
|
Cattle | 1 | 1966 | 3848 | 0.000 |
Why?
|